[3] [4] The appetite suppression is the primary mechanism behind its effectiveness for weight loss
However, these findings are currently limited to animal studies 146
Warehouses Semaglutide (GLP1-S), also designated NN9535, is a synthetic 31 amino acid GLP-1 receptor agonist analog supplied by Nextday Sciences LLC through Nextday Peptides for laboratory and analytical research applications
Start at 0.25 mg weekly for 4 weeks, then escalate to 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg, spending 4 weeks at each dose
Demonstrates persistent cognitive benefits even after treatment cessation, suggesting true structural neurological improvements rather than temporary stimulation, supporting long-term brain health